Hongwei D Yu Selected Research

Alginates

1/2020	Culture of Small Colony Variant of Pseudomonas aeruginosa and Quantitation of its Alginate.
1/2019	Pyrimidine Biosynthesis Regulates the Small-Colony Variant and Mucoidy in Pseudomonas aeruginosa through Sigma Factor Competition.
2/2016	Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa.
10/2013	Draft Genome Sequence of a Stable Mucoid Strain of Pseudomonas aeruginosa PAO581 with a mucA25 Mutation.
10/2013	Draft Genome Sequence of a Mucoid Isolate of Pseudomonas aeruginosa Strain C7447m from a Patient with Cystic Fibrosis.
6/2013	Truncation of type IV pilin induces mucoidy in Pseudomonas aeruginosa strain PAO579.
3/2012	Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN.
4/2009	The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis.
7/2008	ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa.
5/2007	Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongwei D Yu Research Topics

Disease

12	Infections 01/2022 - 04/2007
12	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 05/2007
2	Inflammation (Inflammations) 01/2021 - 04/2009
2	Pneumonia (Pneumonitis) 01/2019 - 03/2012
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Persistent Infection 03/2014
1	Starvation 01/2013
1	Disease Progression 04/2009
1	Necrosis 04/2007
1	Lung Injury 04/2007

Drug/Important Bio-Agent (IBA)

10	AlginatesIBA 01/2020 - 05/2007
3	Sigma FactorIBA 01/2019 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2016
1	CarrageenanIBA 01/2021
1	OligosaccharidesIBA 01/2021
1	Rifaximin (L 105)FDA Link 01/2019
1	NitritesIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 02/2016
1	FluoroquinolonesIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Staphylococcal Protein A (Protein A)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	Phosphodiesterase 5 InhibitorsIBA 09/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007
1	CytokinesIBA 04/2007
1	AerosolsIBA 04/2007
1	Monocyte Chemoattractant ProteinsIBA 04/2007
1	Interleukin-17 (Interleukin 17)IBA 04/2007
1	Complement System Proteins (Complement)IBA 04/2007
1	InterleukinsIBA 04/2007
1	Peroxidase (Myeloperoxidase)IBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007

Therapy/Procedure

1	Therapeutics 01/2022
1	Intraperitoneal Injections 01/2020